INDIA – The Organisation of Pharmaceutical Producers of India (OPPI) has reiterated its focus on achieving better health outcomes for all patients with its new initiative, Bharat Ke Liye.
OPPI, an industry body representing the global research-based pharmaceutical industry in India, has reinforced its commitment towards enabling a healthier India through innovative solutions.
In a press release, the Indian-based pharma body said: “Bharat Ke Liye highlights OPPI’s renewed strategy to reinforce its commitment to India now and in the future.”
The ‘Bharat Ke Liye’ initiative focuses on efforts to reduce the growing disease burden in India, strengthen the country’s healthcare ecosystem, and improve the quality of life of its citizens.
Through its strategic initiative, OPPI aims to celebrate the legacy of the global pharma industry in India, with a strong partnership with the nation spanning over 100 years.
“There will be a renewed focus on strengthening healthcare systems through stronger government collaborations and greater strategic investments to address healthcare issues that are most pressing,” underscored OPPI.
In addition, the new initiative will underscore the significant contributions made by OPPI member companies in various areas of the health sector to find sustainable solutions.
These areas include pharmaceutical research and development (R&D), upholding industry quality standards, manufacturing, supply chain, and patient concern & care, just to name a few.
“As part of this approach, OPPI will focus on 4 critical pillars- enabling access, driving innovation, supporting health systems, and committing strategic investments,” stated the industry body.
According to the company’s statement, access and innovation have always been the two key driving factors for progress in healthcare.
The research-based pharmaceutical industry in India has been driving India’s economic growth and development through technical collaborations, disease awareness programs, patient access initiatives, and drug safety efforts.
OPPI confirmed that its members will bring novel therapies to market that lead to better health outcomes for all and job opportunities in the pharmaceutical sector in India.
“The members will continue their focus on bringing innovative solutions for unmet medical needs and R&D; all in an effort to improve the quality of care and access to healthcare,” said OPPI.
Additionally, OPPI members look forward to exploring new and sophisticated approaches on enhancing access to patients in India and across the world.
Moreover, the ‘Bharat Ke Liye’ initiative aligns with OPPI’s commitment to supporting the nation’s healthcare objectives and putting patients at the core of all decision-making.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
